Stakeholder meeting on product shortages due to manufacturing and quality problems: developing a proactive approach to prevention

• Date:
  Friday, 9 October 2015, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

In October 2013, a workshop held at the European Medicines Agency (EMA) led to the formation of an inter-industry association taskforce to propose possible solutions to the root causes of shortages due to manufacturing and quality problems. EMA is hosting a follow-up workshop on 9 October 2015 to discuss the solutions proposed by industry associations. Registration by invitation only. A live broadcast of the workshop will be available.

Documents

Agenda - Stakeholder meeting on Product Shortages due to manufacturing and quality problems: developing a proactive approach to prevention

AdoptedReference Number: EMA/INS/GMP/665392/2015

Meeting report - Developing a proactive approach to the prevention of medicines shortages due to manufacturing and quality problems

Reference Number: EMA/679967/2015Summary:

Shortages of medicines have been a global problem for the past decade and have also increasingly affected the European Union (EU) with significant impact on patient care.

Presentation - 2015 shortages workshop (Brendan Cuddy)

Presentation - European Medicines Agency initiatives on product shortages due to manufacturing/GMP issues (Brendan Cuddy)

Presentation - Medicinal product shortages: GMP update and ICH Q12 (David Cockburn)

Presentation - Shortages survey 2015 (Maria-Jesus Alcaraz)

Presentation - Inter-association task force: prevention of drug shortages based on quality and manufacturing issues

Presentation - Medicines shortages issues and recent actions: Eurordis perspective (Franà§ois Houà¿ez)

Presentation - Pharmaceutical Group of European Union (Jamie Wilkinson)

Presentation - European Medicines Agency shortages workshop: the European Association of hospitals pharmacists perspective

Presentation - ESMO study of formulary listing, out of pocket cost and actual availability of anti neoplastic agents in Europe: preliminary findings (Nathan I Cherny)

Presentation - Drug shortages project of law in France (Dominique Debourges)

Presentation - Management of medicines shortages in Ireland (John Lynch)